Theresa Sberna, MPH

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, Tantawy MN, Manning HC, Lu P, Shyr Y, Ecsedy J, Belkhiri A, El-Rifai W (2013) Gastroenterology 145(6): 1312-22.e1-8
   › Primary publication · 23993973 (PubMed) · PMC3840093 (PubMed Central)
2. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Cover TL, Peek RM (2013) Gut Microbes 4(6): 482-93
   › Primary publication · 23989802 (PubMed) · PMC3928160 (PubMed Central)
3. Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome. Wang Z, Sun Y, Gao B, Lu Y, Fang R, Gao Y, Xiao T, Liu XY, Pao W, Zhao Y, Chen H, Ji H (2014) Cancer Lett 342(1): 36-42
   › Citation · 23981578 (PubMed) · PMC3981830 (PubMed Central)
4. Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2. Rexer BN, Ghosh R, Narasanna A, Estrada MV, Chakrabarty A, Song Y, Engelman JA, Arteaga CL (2013) Clin Cancer Res 19(19): 5390-401
   › Primary publication · 23948973 (PubMed) · PMC3809918 (PubMed Central)
5. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. Hanker AB, Pfefferle AD, Balko JM, Kuba MG, Young CD, Sánchez V, Sutton CR, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL (2013) Proc Natl Acad Sci U S A 110(35): 14372-7
   › Primary publication · 23940356 (PubMed) · PMC3761610 (PubMed Central)
6. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. Makobongo MO, Einck L, Peek RM, Merrell DS (2013) PLoS One 8(7): e68917
   › Primary publication · 23935905 (PubMed) · PMC3723868 (PubMed Central)
7. An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin. Garner AP, Bialucha CU, Sprague ER, Garrett JT, Sheng Q, Li S, Sineshchekova O, Saxena P, Sutton CR, Chen D, Chen Y, Wang H, Liang J, Das R, Mosher R, Gu J, Huang A, Haubst N, Zehetmeier C, Haberl M, Elis W, Kunz C, Heidt AB, Herlihy K, Murtie J, Schuller A, Arteaga CL, Sellers WR, Ettenberg SA (2013) Cancer Res 73(19): 6024-35
   › Primary publication · 23928993 (PubMed) · PMC3924863 (PubMed Central)
8. Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers. Garrett JT, Sutton CR, Kurupi R, Bialucha CU, Ettenberg SA, Collins SD, Sheng Q, Wallweber J, Defazio-Eli L, Arteaga CL (2013) Cancer Res 73(19): 6013-23
   › Primary publication · 23918797 (PubMed) · PMC3790862 (PubMed Central)
9. The genomic map of breast cancer: which roads lead to better targeted therapies? Balko JM, Stricker TP, Arteaga CL (2013) Breast Cancer Res 15(4): 209
   › Primary publication · 23905624 (PubMed) · PMC3979080 (PubMed Central)
10. Use of the noninvasive entero-test in the detection of Helicobacter pylori in children in an endemic area in Colombia. Arboleda RN, Schneider BG, Bravo LE, Romero-Gallo J, Peek RM, Mera RM, Yepez MC, Campo C, Correa P (2013) J Pediatr Gastroenterol Nutr 57(2): 192-6
    › Primary publication · 23880626 (PubMed) · PMC3725653 (PubMed Central)
11. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL (2013) Breast Cancer Res 15(4): R55
    › Primary publication · 23844554 (PubMed) · PMC3979036 (PubMed Central)
12. Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data. Lasko TA, Denny JC, Levy MA (2013) PLoS One 8(6): e66341
    › Primary publication · 23826094 (PubMed) · PMC3691199 (PubMed Central)
13. 5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer? Belkhiri A, El-Rifai W (2014) Gut 63(4): 538-9
    › Primary publication · 23812322 (PubMed) · PMC4035300 (PubMed Central)
14. Optimal targeting of HER2-PI3K signaling in breast cancer: mechanistic insights and clinical implications. Rexer BN, Arteaga CL (2013) Cancer Res 73(13): 3817-20
    › Primary publication · 23794708 (PubMed) · PMC3702635 (PubMed Central)
15. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W (2013) PLoS One 8(5): e64463
    › Primary publication · 23724052 (PubMed) · PMC3665888 (PubMed Central)
16. Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors. Zaika E, Bhardwaj V, Wei J, Washington MK, Souza R, El-Rifai W, Zaika A (2013) PLoS One 8(5): e64306
    › Primary publication · 23717592 (PubMed) · PMC3661465 (PubMed Central)
17. The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin. Lim J, Duong T, Lee G, Seong BL, El-Rifai W, Ruley HE, Jo D (2013) Biomaterials 34(26): 6261-71
    › Primary publication · 23714245 (PubMed)
18. Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer. Dennison JB, Molina JR, Mitra S, González-Angulo AM, Balko JM, Kuba MG, Sanders ME, Pinto JA, Gómez HL, Arteaga CL, Brown RE, Mills GB (2013) Clin Cancer Res 19(13): 3703-13
    › Primary publication · 23697991 (PubMed) · PMC3727144 (PubMed Central)
19. Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. Sierra JC, Hobbs S, Chaturvedi R, Yan F, Wilson KT, Peek RM, Polk DB (2013) Am J Physiol Gastrointest Liver Physiol 305(2): G196-203
    › Primary publication · 23681474 (PubMed) · PMC3725681 (PubMed Central)
20. Genome sequences of 65 Helicobacter pylori strains isolated from asymptomatic individuals and patients with gastric cancer, peptic ulcer disease, or gastritis. Blanchard TG, Czinn SJ, Correa P, Nakazawa T, Keelan M, Morningstar L, Santana-Cruz I, Maroo A, McCracken C, Shefchek K, Daugherty S, Song Y, Fraser CM, Fricke WF (2013) Pathog Dis 68(2): 39-43
    › Primary publication · 23661595 (PubMed) · PMC3780442 (PubMed Central)
21. Phosphatase and tensin homolog deficiency and resistance to trastuzumab and chemotherapy. Rexer BN, Shyr Y, Arteaga CL (2013) J Clin Oncol 31(17): 2073-5
    › Primary publication · 23650407 (PubMed)
22. Helicobacter pylori in gastric carcinogenesis: mechanisms. Wroblewski LE, Peek RM (2013) Gastroenterol Clin North Am 42(2): 285-98
    › Primary publication · 23639641 (PubMed) · PMC3648881 (PubMed Central)
23. Gastric cancer: overview. Correa P (2013) Gastroenterol Clin North Am 42(2): 211-7
    › Primary publication · 23639637 (PubMed) · PMC3995345 (PubMed Central)
24. Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling. Young CD, Pfefferle AD, Owens P, Kuba MG, Rexer BN, Balko JM, Sánchez V, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL (2013) Cancer Res 73(13): 4075-85
    › Primary publication · 23633485 (PubMed) · PMC3702683 (PubMed Central)
25. Phylogeographic origin of Helicobacter pylori determines host-adaptive responses upon coculture with gastric epithelial cells. Sheh A, Chaturvedi R, Merrell DS, Correa P, Wilson KT, Fox JG (2013) Infect Immun 81(7): 2468-77
    › Primary publication · 23630959 (PubMed) · PMC3697613 (PubMed Central)
26. Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy. Mani S, Chen Y, Li X, Arlinghaus L, Chakravarthy AB, Abramson V, Bhave SR, Levy MA, Xu H, Yankeelov TE (2013) J Am Med Inform Assoc 20(4): 688-95
    › Primary publication · 23616206 (PubMed) · PMC3721158 (PubMed Central)
27. Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex. Qi M, Williams JA, Chu H, Chen X, Wang JJ, Ding L, Akhirome E, Wen X, Lapierre LA, Goldenring JR, Spearman P (2013) PLoS Pathog 9(4): e1003278
    › Primary publication · 23592992 (PubMed) · PMC3616983 (PubMed Central)
28. Clinical analysis and interpretation of cancer genome data. Van Allen EM, Wagle N, Levy MA (2013) J Clin Oncol 31(15): 1825-33
    › Primary publication · 23589549 (PubMed) · PMC4878102 (PubMed Central)
29. The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. Khurana SS, Riehl TE, Moore BD, Fassan M, Rugge M, Romero-Gallo J, Noto J, Peek RM, Stenson WF, Mills JC (2013) J Biol Chem 288(22): 16085-97
    › Primary publication · 23589310 (PubMed) · PMC3668764 (PubMed Central)
30. Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W (2014) Gut 63(4): 540-51
    › Primary publication · 23580780 (PubMed) · PMC3825783 (PubMed Central)
31. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM, Algood HM, Cover TL (2013) Infect Immun 81(6): 2258-67
    › Primary publication · 23569116 (PubMed) · PMC3676043 (PubMed Central)
32. Gastric cancer prevention by demethylation. Schneider BG, Peek RM (2013) Cancer Prev Res (Phila) 6(4): 253-6
    › Primary publication · 23559450 (PubMed) · PMC3620723 (PubMed Central)
33. Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer. Yu KD, Zhu R, Zhan M, Rodriguez AA, Yang W, Wong S, Makris A, Lehmann BD, Chen X, Mayer I, Pietenpol JA, Shao ZM, Symmans WF, Chang JC (2013) Clin Cancer Res 19(10): 2723-33
    › Primary publication · 23549873 (PubMed) · PMC3655097 (PubMed Central)
34. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Erdogan B, Bosompem A, Peng D, Han L, Smith E, Kennedy ME, Alford CE, Wu H, Zhao Z, Mosse CA, El-Rifai W, Kim AS (2013) Leuk Lymphoma 54(12): 2720-7
    › Primary publication · 23547841 (PubMed) · PMC4120331 (PubMed Central)
35. Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer. Sang J, Acquaviva J, Friedland JC, Smith DL, Sequeira M, Zhang C, Jiang Q, Xue L, Lovly CM, Jimenez JP, Shaw AT, Doebele RC, He S, Bates RC, Camidge DR, Morris SW, El-Hariry I, Proia DA (2013) Cancer Discov 3(4): 430-43
    › Primary publication · 23533265 (PubMed) · PMC4086149 (PubMed Central)
36. Nutrient-based dietary patterns of head and neck squamous cell cancer: a factor analysis in Uruguay. Deneo-Pellegrini H, Boffetta P, De Stefani E, Correa P, Ronco AL, Acosta G, Mendilaharsu M, Silva C, Luaces ME (2013) Cancer Causes Control 24(6): 1167-74
    › Primary publication · 23532561 (PubMed)
37. Dietary patterns and risk of cancers of the upper aerodigestive tract: a factor analysis in Uruguay. De Stefani E, Boffetta P, Correa P, Deneo-Pellegrini H, Ronco AL, Acosta G, Mendilaharsu M (2013) Nutr Cancer 65(3): 384-9
    › Primary publication · 23530637 (PubMed)
38. Meat, milk and risk of lymphoid malignancies: a case-control study in Uruguay. De Stefani E, Ronco AL, Deneo-Pellegrini H, Boffetta P, Correa P, Barrios E, Acosta G, Mendilaharsu M (2013) Nutr Cancer 65(3): 375-83
    › Primary publication · 23530636 (PubMed)
39. A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL, COG Ewing Sarcoma Biology Committee (2013) Front Oncol : 57
    › Primary publication · 23519678 (PubMed) · PMC3602933 (PubMed Central)
40. The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. Capoccia BJ, Jin RU, Kong YY, Peek RM, Fassan M, Rugge M, Mills JC (2013) J Clin Invest 123(4): 1475-91
    › Primary publication · 23478405 (PubMed) · PMC3613919 (PubMed Central)
41. Functional plasticity in the type IV secretion system of Helicobacter pylori. Barrozo RM, Cooke CL, Hansen LM, Lam AM, Gaddy JA, Johnson EM, Cariaga TA, Suarez G, Peek RM, Cover TL, Solnick JV (2013) PLoS Pathog 9(2): e1003189
    › Primary publication · 23468628 (PubMed) · PMC3585145 (PubMed Central)
42. Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells. Wang L, Cao H, Lu N, Liu L, Wang B, Hu T, Israel DA, Peek RM, Polk DB, Yan F (2013) PLoS One 8(2): e56666
    › Primary publication · 23457600 (PubMed) · PMC3573001 (PubMed Central)
43. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Peña EM, Peña R, Correa P, Martínez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH (2013) JAMA 309(6): 578-86
    › Primary publication · 23403682 (PubMed) · PMC3697935 (PubMed Central)
44. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. Bhola NE, Balko JM, Dugger TC, Kuba MG, Sánchez V, Sanders M, Stanford J, Cook RS, Arteaga CL (2013) J Clin Invest 123(3): 1348-58
    › Primary publication · 23391723 (PubMed) · PMC3582135 (PubMed Central)
45. A Rab11a-Rab8a-Myo5B network promotes stretch-regulated exocytosis in bladder umbrella cells. Khandelwal P, Prakasam HS, Clayton DR, Ruiz WG, Gallo LI, van Roekel D, Lukianov S, Peränen J, Goldenring JR, Apodaca G (2013) Mol Biol Cell 24(7): 1007-19
    › Primary publication · 23389633 (PubMed) · PMC3608489 (PubMed Central)
46. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Cleveland SM, Smith S, Tripathi R, Mathias EM, Goodings C, Elliott N, Peng D, El-Rifai W, Yi D, Chen X, Li L, Mullighan C, Downing JR, Love P, Davé UP (2013) Stem Cells 31(5): 882-94
    › Primary publication · 23378057 (PubMed) · PMC3652616 (PubMed Central)
47. Helicobacter pylori promotes the expression of Krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo. Noto JM, Khizanishvili T, Chaturvedi R, Piazuelo MB, Romero-Gallo J, Delgado AG, Khurana SS, Sierra JC, Krishna US, Suarez G, Powell AE, Goldenring JR, Coffey RJ, Yang VW, Correa P, Mills JC, Wilson KT, Peek RM (2013) PLoS One 8(1): e54344
    › Primary publication · 23372710 (PubMed) · PMC3553174 (PubMed Central)
48. John Gaetano Forte, PhD. Machen T, Okamoto C, Chew C, Goldenring JR (2013) Gastroenterology 144(3): 471-3
    › Primary publication · 23352594 (PubMed)
49. Rab25 regulates integrin expression in polarized colonic epithelial cells. Krishnan M, Lapierre LA, Knowles BC, Goldenring JR (2013) Mol Biol Cell 24(6): 818-31
    › Primary publication · 23345591 (PubMed) · PMC3596252 (PubMed Central)
50. Patient-derived breast tumor xenografts facilitating personalized cancer therapy. Landis MD, Lehmann BD, Pietenpol JA, Chang JC (2013) Breast Cancer Res 15(1): 201
    › Primary publication · 23339383 (PubMed) · PMC3672825 (PubMed Central)
51. Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013) Oncogene 32(47): 5429-38
    › Primary publication · 23318429 (PubMed) · PMC3898328 (PubMed Central)
52. Rab11-family interacting proteins define spatially and temporally distinct regions within the dynamic Rab11a-dependent recycling system. Baetz NW, Goldenring JR (2013) Mol Biol Cell 24(5): 643-58
    › Primary publication · 23283983 (PubMed) · PMC3583667 (PubMed Central)
53. Identifying the status of genetic lesions in cancer clinical trial documents using machine learning. Wu Y, Levy MA, Micheel CM, Yeh P, Tang B, Cantrell MJ, Cooreman SM, Xu H (2012) BMC Genomics : S21
    › Primary publication · 23282337 (PubMed) · PMC3535695 (PubMed Central)
54. Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives. Ye F, Bauer JA, Pietenpol JA, Shyr Y (2012) BMC Genomics : S3
    › Primary publication · 23281588 (PubMed) · PMC3535706 (PubMed Central)
55. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. González CA, Sanz-Anquela JM, Gisbert JP, Correa P (2013) Int J Cancer 133(5): 1023-32
    › Primary publication · 23280711 (PubMed) · PMC3732516 (PubMed Central)
56. Polysomnographic findings in dementia with Lewy bodies. Pao WC, Boeve BF, Ferman TJ, Lin SC, Smith GE, Knopman DS, Graff-Radford NR, Petersen RC, Parisi JE, Dickson DW, Silber MH (2013) Neurologist 19(1): 1-6
    › Primary publication · 23269098 (PubMed) · PMC3587292 (PubMed Central)
57. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC, Tan S, Morgan DR, Wilson KT, Bravo LE, Correa P, Cover TL, Amieva MR, Peek RM (2013) J Clin Invest 123(1): 479-92
    › Primary publication · 23257361 (PubMed) · PMC3533289 (PubMed Central)
58. When guests simply will not leave. Wroblewski LE, Peek RM (2012) Cell Host Microbe 12(6): 733-4
    › Primary publication · 23245316 (PubMed) · PMC3593715 (PubMed Central)
59. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam DB, Haslam D, Goldenring JR, Lacy DB (2012) PLoS Pathog 8(12): e1003072
    › Primary publication · 23236283 (PubMed) · PMC3516567 (PubMed Central)
60. Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells. Lim J, Duong T, Do N, Do P, Kim J, Kim H, El-Rifai W, Ruley HE, Jo D (2013) Clin Cancer Res 19(3): 680-90
    › Primary publication · 23230322 (PubMed) · PMC4039637 (PubMed Central)
61. Dual blockade of HER2 in HER2-overexpressing tumor cells does not completely eliminate HER3 function. Garrett JT, Sutton CR, Kuba MG, Cook RS, Arteaga CL (2013) Clin Cancer Res 19(3): 610-9
    › Primary publication · 23224399 (PubMed) · PMC3563762 (PubMed Central)
62. Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Torres J, Correa P, Ferreccio C, Hernandez-Suarez G, Herrero R, Cavazza-Porro M, Dominguez R, Morgan D (2013) Cancer Causes Control 24(2): 249-56
    › Primary publication · 23224271 (PubMed) · PMC3697934 (PubMed Central)
63. Risk factors for gastric cancer in Latin America: a meta-analysis. Bonequi P, Meneses-González F, Correa P, Rabkin CS, Camargo MC (2013) Cancer Causes Control 24(2): 217-31
    › Primary publication · 23224270 (PubMed) · PMC3961831 (PubMed Central)
64. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, Williams CS (2013) Cancer Res 73(3): 1245-55
    › Primary publication · 23221387 (PubMed) · PMC3563732 (PubMed Central)
65. Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Chakrabarty A, Bhola NE, Sutton C, Ghosh R, Kuba MG, Dave B, Chang JC, Arteaga CL (2013) Cancer Res 73(3): 1190-200
    › Primary publication · 23204226 (PubMed) · PMC3563941 (PubMed Central)
66. Gastric-to-intestinal transdifferentiation and cancer. Noto JM, Peek RM (2012) Proc Natl Acad Sci U S A 109(50): 20173-4
    › Primary publication · 23184987 (PubMed) · PMC3528517 (PubMed Central)
67. C. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behavior. Correa P, LeBoeuf B, García LR (2012) PLoS Genet 8(11): e1003015
    › Primary publication · 23166505 (PubMed) · PMC3499252 (PubMed Central)
68. Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. Zhu S, Hong J, Tripathi MK, Sehdev V, Belkhiri A, El-Rifai W (2013) Mol Cancer Res 11(1): 86-94
    › Primary publication · 23160836 (PubMed) · PMC3552044 (PubMed Central)
69. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF, Lin D, Chanock SJ, Rothman N (2012) Nat Genet 44(12): 1330-5
    › Primary publication · 23143601 (PubMed) · PMC4169232 (PubMed Central)
70. Chronic Helicobacter pylori infection and DNA-damaged stem cells: a recipe for disaster. Peek RM (2013) Dig Dis Sci 58(1): 13-6
    › Primary publication · 23108565 (PubMed) · PMC3558627 (PubMed Central)
71. Sonic Hedgehog contributes to gastric mucosal restitution after injury. Xiao C, Feng R, Engevik AC, Martin JR, Tritschler JA, Schumacher M, Koncar R, Roland J, Nam KT, Goldenring JR, Zavros Y (2013) Lab Invest 93(1): 96-111
    › Primary publication · 23090636 (PubMed) · PMC3730822 (PubMed Central)
72. Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer. Fox EM, Arteaga CL, Miller TW (2012) Front Oncol : 145
    › Primary publication · 23087906 (PubMed) · PMC3472546 (PubMed Central)
73. Prospects and challenges for the development of new therapies for Ewing sarcoma. Grohar PJ, Helman LJ (2013) Pharmacol Ther 137(2): 216-24
    › Primary publication · 23085431 (PubMed) · PMC7243921 (PubMed Central)
74. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. O'Neal RL, Nam KT, LaFleur BJ, Barlow B, Nozaki K, Lee HJ, Kim WH, Yang HK, Shi C, Maitra A, Montgomery E, Washington MK, El Rifai W, Drapkin RI, Goldenring JR (2013) Hum Pathol 44(5): 734-42
    › Primary publication · 23084584 (PubMed) · PMC3556378 (PubMed Central)
75. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels. Yamagata Y, Aikou S, Fukushima T, Kataoka H, Seto Y, Esumi H, Kaminishi M, Goldenring JR, Nomura S (2012) Am J Physiol Gastrointest Liver Physiol 303(11): G1254-61
    › Primary publication · 23064758 (PubMed) · PMC4888532 (PubMed Central)
76. Haem oxygenase-1 inhibits phosphorylation of the Helicobacter pylori oncoprotein CagA in gastric epithelial cells. Gobert AP, Verriere T, de Sablet T, Peek RM, Chaturvedi R, Wilson KT (2013) Cell Microbiol 15(1): 145-56
    › Primary publication · 23051580 (PubMed) · PMC3524338 (PubMed Central)
77. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Epplein M, Zheng W, Xiang YB, Peek RM, Li H, Correa P, Gao J, Michel A, Pawlita M, Cai Q, Shu XO (2012) Cancer Epidemiol Biomarkers Prev 21(12): 2185-92
    › Primary publication · 23035179 (PubMed) · PMC3518572 (PubMed Central)
78. Translating genomic information into clinical medicine: lung cancer as a paradigm. Levy MA, Lovly CM, Pao W (2012) Genome Res 22(11): 2101-8
    › Primary publication · 23019146 (PubMed) · PMC3483539 (PubMed Central)
79. Genetic manipulation of a naturally competent bacterium, Helicobacter pylori. Noto JM, Peek RM (2012) Methods Mol Biol : 51-9
    › Primary publication · 23015491 (PubMed) · PMC3544407 (PubMed Central)
80. The Helicobacter pylori cag Pathogenicity Island. Noto JM, Peek RM (2012) Methods Mol Biol : 41-50
    › Primary publication · 23015490 (PubMed) · PMC3547679 (PubMed Central)
81. Helicobacter pylori: an overview. Noto JM, Peek RM (2012) Methods Mol Biol : 7-10
    › Primary publication · 23015485 (PubMed)
82. Processed meat consumption and risk of cancer: a multisite case-control study in Uruguay. De Stefani E, Boffetta P, Ronco AL, Deneo-Pellegrini H, Correa P, Acosta G, Mendilaharsu M, Luaces ME, Silva C (2012) Br J Cancer 107(9): 1584-8
    › Primary publication · 23011480 (PubMed) · PMC3493769 (PubMed Central)
83. Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer. Foo J, Chmielecki J, Pao W, Michor F (2012) J Thorac Oncol 7(10): 1583-93
    › Primary publication · 22982659 (PubMed) · PMC3693219 (PubMed Central)
84. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansén S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Jänne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M (2012) Cell 150(6): 1107-20
    › Primary publication · 22980975 (PubMed) · PMC3557932 (PubMed Central)
85. The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas. Sehdev V, Katsha A, Ecsedy J, Zaika A, Belkhiri A, El-Rifai W (2013) Cancer 119(4): 904-14
    › Primary publication · 22972611 (PubMed) · PMC3524359 (PubMed Central)
86. Targeting mutant p53 in human tumors. Lehmann BD, Pietenpol JA (2012) J Clin Oncol 30(29): 3648-50
    › Primary publication · 22965952 (PubMed)
87. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. Feng J, Pan X, Yu J, Chen Z, Xu H, El-Rifai W, Zhang G, Xu Z (2012) PLoS One 7(9): e44478
    › Primary publication · 22957075 (PubMed) · PMC3434136 (PubMed Central)
88. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, Riely GJ, Kris MG, Miller VA, Ladanyi M, Politi K, Pao W (2012) Cancer Discov 2(10): 922-33
    › Primary publication · 22956644 (PubMed) · PMC3473100 (PubMed Central)
89. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Dikranian K, Kim J, Stewart FR, Levy MA, Holtzman DM (2012) Int J Clin Exp Pathol 5(6): 482-95
    › Primary publication · 22949930 (PubMed) · PMC3430100 (PubMed Central)
90. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Sousa JF, Ham AJ, Whitwell C, Nam KT, Lee HJ, Yang HK, Kim WH, Zhang B, Li M, LaFleur B, Liebler DC, Goldenring JR (2012) Am J Pathol 181(5): 1560-72
    › Primary publication · 22944598 (PubMed) · PMC3483808 (PubMed Central)
91. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S, Gabler F, Wilkening I, Heynck S, Heuckmann JM, Lu X, Carter SL, Cibulskis K, Banerji S, Getz G, Park KS, Rauh D, Grütter C, Fischer M, Pasqualucci L, Wright G, Wainer Z, Russell P, Petersen I, Chen Y, Stoelben E, Ludwig C, Schnabel P, Hoffmann H, Muley T, Brockmann M, Engel-Riedel W, Muscarella LA, Fazio VM, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman DA, Snijders PJ, Cappuzzo F, Ligorio C, Damiani S, Field J, Solberg S, Brustugun OT, Lund-Iversen M, Sänger J, Clement JH, Soltermann A, Moch H, Weder W, Solomon B, Soria JC, Validire P, Besse B, Brambilla E, Brambilla C, Lantuejoul S, Lorimier P, Schneider PM, Hallek M, Pao W, Meyerson M, Sage J, Shendure J, Schneider R, Büttner R, Wolf J, Nürnberg P, Perner S, Heukamp LC, Brindle PK, Haas S, Thomas RK (2012) Nat Genet 44(10): 1104-10
    › Primary publication · 22941188 (PubMed) · PMC4915822 (PubMed Central)
92. Polymorphisms of the acid sensing histidine kinase gene arsS in Helicobacter pylori populations from anatomically distinct gastric sites. Hallinger DR, Romero-Gallo J, Peek RM, Forsyth MH (2012) Microb Pathog 53(5-6): 227-33
    › Primary publication · 22940419 (PubMed) · PMC3479636 (PubMed Central)
93. Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. Sangai T, Akcakanat A, Chen H, Tarco E, Wu Y, Do KA, Miller TW, Arteaga CL, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F (2012) Clin Cancer Res 18(20): 5816-28
    › Primary publication · 22932669 (PubMed) · PMC3772348 (PubMed Central)
94. Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Wei J, Noto J, Zaika E, Romero-Gallo J, Correa P, El-Rifai W, Peek RM, Zaika A (2012) Proc Natl Acad Sci U S A 109(38): E2543-50
    › Primary publication · 22927405 (PubMed) · PMC3458371 (PubMed Central)
95. Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Heuckmann JM, Balke-Want H, Malchers F, Peifer M, Sos ML, Koker M, Meder L, Lovly CM, Heukamp LC, Pao W, Küppers R, Thomas RK (2012) Clin Cancer Res 18(17): 4682-90
    › Primary publication · 22912387 (PubMed)
96. Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification. Balko JM, Mayer IA, Sanders ME, Miller TW, Kuba MG, Meszoely IM, Wagle N, Garraway LA, Arteaga CL (2012) Mol Cancer Ther 11(10): 2301-5
    › Primary publication · 22879364 (PubMed) · PMC3682668 (PubMed Central)
97. Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives. Wang Q, Xia J, Jia P, Pao W, Zhao Z (2013) Brief Bioinform 14(4): 506-19
    › Primary publication · 22877769 (PubMed) · PMC3713712 (PubMed Central)
98. TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer. Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, Pietenpol JA (2012) Cancer Inform : 147-56
    › Primary publication · 22872785 (PubMed) · PMC3412597 (PubMed Central)
99. MTG16 contributes to colonic epithelial integrity in experimental colitis. Williams CS, Bradley AM, Chaturvedi R, Singh K, Piazuelo MB, Chen X, McDonough EM, Schwartz DA, Brown CT, Allaman MM, Coburn LA, Horst SN, Beaulieu DB, Choksi YA, Washington MK, Williams AD, Fisher MA, Zinkel SS, Peek RM, Wilson KT, Hiebert SW (2013) Gut 62(10): 1446-55
    › Primary publication · 22833394 (PubMed) · PMC3663894 (PubMed Central)
100. Strategies for overcoming EGFR resistance in the treatment of advanced-stage NSCLC. Lovly CM, Horn L (2012) Curr Treat Options Oncol 13(4): 516-26
     › Primary publication · 22833206 (PubMed)
101. Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas. Johnson ML, Sima CS, Chaft J, Paik PK, Pao W, Kris MG, Ladanyi M, Riely GJ (2013) Cancer 119(2): 356-62
     › Primary publication · 22810899 (PubMed) · PMC3966555 (PubMed Central)
102. Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. Shaikh FY, Utley TJ, Craven RE, Rogers MC, Lapierre LA, Goldenring JR, Crowe JE (2012) PLoS One 7(7): e40826
     › Primary publication · 22808269 (PubMed) · PMC3396619 (PubMed Central)
103. BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, Atefi M, Su Z, Branch S, Lyle PL, Hicks DJ, Bozon V, Glaspy JA, Rosen N, Solit DB, Netterville JL, Vnencak-Jones CL, Sosman JA, Ribas A, Zhao Z, Pao W (2012) Cancer Discov 2(9): 791-7
     › Primary publication · 22798288 (PubMed) · PMC3449158 (PubMed Central)
104. Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Ohashi K, Sequist LV, Arcila ME, Moran T, Chmielecki J, Lin YL, Pan Y, Wang L, de Stanchina E, Shien K, Aoe K, Toyooka S, Kiura K, Fernandez-Cuesta L, Fidias P, Yang JC, Miller VA, Riely GJ, Kris MG, Engelman JA, Vnencak-Jones CL, Dias-Santagata D, Ladanyi M, Pao W (2012) Proc Natl Acad Sci U S A 109(31): E2127-33
     › Primary publication · 22773810 (PubMed) · PMC3411967 (PubMed Central)
105. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression. Weis VG, Sousa JF, LaFleur BJ, Nam KT, Weis JA, Finke PE, Ameen NA, Fox JG, Goldenring JR (2013) Gut 62(9): 1270-9
     › Primary publication · 22773549 (PubMed) · PMC3762676 (PubMed Central)
106. Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach. Rau TT, Rogler A, Frischauf M, Jung A, Konturek PC, Dimmler A, Faller G, Sehnert B, El-Rifai W, Hartmann A, Voll RE, Schneider-Stock R (2012) Am J Pathol 181(2): 487-98
     › Primary publication · 22749770 (PubMed) · PMC3409443 (PubMed Central)
107. Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma. Hong J, Katsha A, Lu P, Shyr Y, Belkhiri A, El-Rifai W (2012) Cancer Res 72(17): 4504-14
     › Primary publication · 22745369 (PubMed) · PMC3432752 (PubMed Central)
108. Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. Yatabe Y, Pao W, Jett JR (2012) J Thorac Oncol 7(5): 775-6
     › Primary publication · 22722783 (PubMed)
109. Consensus rules in variant detection from next-generation sequencing data. Jia P, Li F, Xia J, Chen H, Ji H, Pao W, Zhao Z (2012) PLoS One 7(6): e38470
     › Primary publication · 22715385 (PubMed) · PMC3371040 (PubMed Central)
110. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Loh JT, Friedman DB, Piazuelo MB, Bravo LE, Wilson KT, Peek RM, Correa P, Cover TL (2012) Infect Immun 80(9): 3094-106
     › Primary publication · 22710874 (PubMed) · PMC3418733 (PubMed Central)
111. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, González-Angulo AM, Mills GB, Pinto JA, Gómez HL, Arteaga CL (2012) Nat Med 18(7): 1052-9
     › Primary publication · 22683778 (PubMed) · PMC3693569 (PubMed Central)
112. Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration. Lim J, Kim J, Duong T, Lee G, Kim J, Yoon J, Kim J, Kim H, Ruley HE, El-Rifai W, Jo D (2012) Mol Ther 20(8): 1540-9
     › Primary publication · 22617107 (PubMed) · PMC3412482 (PubMed Central)
113. Resistance to TRAIL is mediated by DARPP-32 in gastric cancer. Belkhiri A, Zhu S, Chen Z, Soutto M, El-Rifai W (2012) Clin Cancer Res 18(14): 3889-900
     › Primary publication · 22589394 (PubMed) · PMC3399047 (PubMed Central)
114. Screening for germline EGFR T790M mutations through lung cancer genotyping. Oxnard GR, Miller VA, Robson ME, Azzoli CG, Pao W, Ladanyi M, Arcila ME (2012) J Thorac Oncol 7(6): 1049-52
     › Primary publication · 22588155 (PubMed) · PMC3354706 (PubMed Central)
115. Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk. Chaturvedi R, de Sablet T, Peek RM, Wilson KT (2012) Gut Microbes 3(1): 48-56
     › Primary publication · 22555547 (PubMed) · PMC3337125 (PubMed Central)
116. Phosphorylation of Rab11-FIP2 regulates polarity in MDCK cells. Lapierre LA, Avant KM, Caldwell CM, Oztan A, Apodaca G, Knowles BC, Roland JT, Ducharme NA, Goldenring JR (2012) Mol Biol Cell 23(12): 2302-18
     › Primary publication · 22553350 (PubMed) · PMC3374749 (PubMed Central)
117. MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, Engelman JA (2012) Cancer Res 72(13): 3228-37
     › Primary publication · 22552284 (PubMed) · PMC3515079 (PubMed Central)
118. New approaches to targeted therapy in lung cancer. Pao W (2012) Proc Am Thorac Soc 9(2): 72-3
     › Primary publication · 22550248 (PubMed) · PMC3359104 (PubMed Central)
119. Food groups and risk of prostate cancer: a case-control study in Uruguay. Deneo-Pellegrini H, Ronco AL, De Stefani E, Boffetta P, Correa P, Mendilaharsu M, Acosta G (2012) Cancer Causes Control 23(7): 1031-8
     › Primary publication · 22544454 (PubMed)
120. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. Lovly CM, Dahlman KB, Fohn LE, Su Z, Dias-Santagata D, Hicks DJ, Hucks D, Berry E, Terry C, Duke M, Su Y, Sobolik-Delmaire T, Richmond A, Kelley MC, Vnencak-Jones CL, Iafrate AJ, Sosman J, Pao W (2012) PLoS One 7(4): e35309
     › Primary publication · 22536370 (PubMed) · PMC3335021 (PubMed Central)
121. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue. Sprung RW, Martinez MA, Carpenter KL, Ham AJ, Washington MK, Arteaga CL, Sanders ME, Liebler DC (2012) J Proteome Res 11(6): 3498-505
     › Primary publication · 22530795 (PubMed) · PMC3368395 (PubMed Central)
122. NGS catalog: A database of next generation sequencing studies in humans. Xia J, Wang Q, Jia P, Wang B, Pao W, Zhao Z (2012) Hum Mutat 33(6): E2341-55
     › Primary publication · 22517761 (PubMed) · PMC4431973 (PubMed Central)
123. Nutrient-derived dietary patterns and risk of colorectal cancer: a factor analysis in Uruguay. De Stefani E, Ronco AL, Boffetta P, Deneo-Pellegrini H, Correa P, Acosta G, Mendilaharsu M (2012) Asian Pac J Cancer Prev 13(1): 231-5
     › Primary publication · 22502675 (PubMed)
124. Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications. Rexer BN, Arteaga CL (2012) Crit Rev Oncog 17(1): 1-16
     › Primary publication · 22471661 (PubMed) · PMC3394454 (PubMed Central)
125. HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation. Vaught DB, Stanford JC, Young C, Hicks DJ, Wheeler F, Rinehart C, Sánchez V, Koland J, Muller WJ, Arteaga CL, Cook RS (2012) Cancer Res 72(10): 2672-82
     › Primary publication · 22461506 (PubMed) · PMC3693553 (PubMed Central)
126. Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: a host and environment interaction in gastric cancer. López-Carrillo L, Camargo MC, Schneider BG, Sicinschi LA, Hernández-Ramírez RU, Correa P, Cebrian ME (2012) Food Chem Toxicol 50(6): 2118-22
     › Primary publication · 22414649 (PubMed) · PMC3636974 (PubMed Central)
127. Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature. Nam KT, O'Neal R, Lee YS, Lee YC, Coffey RJ, Goldenring JR (2012) Lab Invest 92(6): 883-95
     › Primary publication · 22411066 (PubMed) · PMC3584162 (PubMed Central)
128. Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians. Ek C, Whary MT, Ihrig M, Bravo LE, Correa P, Fox JG (2012) Helicobacter 17(2): 107-15
     › Primary publication · 22404440 (PubMed) · PMC3305284 (PubMed Central)
129. Non-invasive genotyping of Helicobacter pylori cagA, vacA, and hopQ from asymptomatic children. Sicinschi LA, Correa P, Bravo LE, Peek RM, Wilson KT, Loh JT, Yepez MC, Gold BD, Thompson DT, Cover TL, Schneider BG (2012) Helicobacter 17(2): 96-106
     › Primary publication · 22404439 (PubMed) · PMC3305281 (PubMed Central)
130. Chipping away at the lung cancer genome. Pao W, Hutchinson KE (2012) Nat Med 18(3): 349-51
     › Primary publication · 22395697 (PubMed)
131. Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis. Correa P, Piazuelo MB (2012) Gut Liver 6(1): 21-8
     › Primary publication · 22375167 (PubMed) · PMC3286735 (PubMed Central)
132. Effect of Helicobacter pylori cdrA on interleukin-8 secretions and nuclear factor kappa B activation. Takeuchi H, Zhang YN, Israel DA, Peek RM, Kamioka M, Yanai H, Morimoto N, Sugiura T (2012) World J Gastroenterol 18(5): 425-34
     › Primary publication · 22346248 (PubMed) · PMC3270507 (PubMed Central)
133. Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigms. Balko JM, Arteaga CL (2012) Mol Diagn Ther 16(1): 1-6
     › Primary publication · 22339590 (PubMed)
134. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Raju D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo-Mata E, Gupta V, Blanke SR, Delgado A, Romero-Gallo J, Ramjeet MS, Mascarenhas H, Peek RM, Correa P, Streutker C, Hold G, Kunstmann E, Yoshimori T, Silverberg MS, Girardin SE, Philpott DJ, El Omar E, Jones NL (2012) Gastroenterology 142(5): 1160-71
     › Primary publication · 22333951 (PubMed) · PMC3336037 (PubMed Central)
135. Escaping ALK inhibition: mechanisms of and strategies to overcome resistance. Lovly CM, Pao W (2012) Sci Transl Med 4(120): 120ps2
     › Primary publication · 22323827 (PubMed)
136. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Zhang Y, Sun Y, Pan Y, Li C, Shen L, Li Y, Luo X, Ye T, Wang R, Hu H, Li H, Wang L, Pao W, Chen H (2012) Clin Cancer Res 18(7): 1947-53
     › Primary publication · 22317764 (PubMed) · PMC3319848 (PubMed Central)
137. Long-term effects of clearing Helicobacter pylori on growth in school-age children. Mera RM, Bravo LE, Goodman KJ, Yepez MC, Correa P (2012) Pediatr Infect Dis J 31(3): 263-6
     › Primary publication · 22315005 (PubMed) · PMC3415984 (PubMed Central)
138. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Sehdev V, Peng D, Soutto M, Washington MK, Revetta F, Ecsedy J, Zaika A, Rau TT, Schneider-Stock R, Belkhiri A, El-Rifai W (2012) Mol Cancer Ther 11(3): 763-74
     › Primary publication · 22302096 (PubMed) · PMC3297687 (PubMed Central)
139. Impact of genomics on personalized cancer medicine. Arteaga CL, Baselga J (2012) Clin Cancer Res 18(3): 612-8
     › Primary publication · 22298893 (PubMed)
140. Optical imaging of metabolism in HER2 overexpressing breast cancer cells. Walsh A, Cook RS, Rexer B, Arteaga CL, Skala MC (2012) Biomed Opt Express 3(1): 75-85
     › Primary publication · 22254170 (PubMed) · PMC3255344 (PubMed Central)
141. Meat consumption, cooking methods, mutagens, and risk of squamous cell carcinoma of the esophagus: a case-control study in Uruguay. De Stefani E, Deneo-Pellegrini H, Ronco AL, Boffetta P, Correa P, Aune D, Mendilaharsu M, Acosta G, Silva C, Landó G, Luaces ME (2012) Nutr Cancer 64(2): 294-9
     › Primary publication · 22242927 (PubMed)
142. Natural history of Helicobacter pylori infection in Mexican schoolchildren: incidence and spontaneous clearance. Duque X, Vilchis J, Mera R, Trejo-Valdivia B, Goodman KJ, Mendoza ME, Navarro F, Roque V, Moran S, Torres J, Correa P (2012) J Pediatr Gastroenterol Nutr 55(2): 209-16
     › Primary publication · 22227999 (PubMed) · PMC3697926 (PubMed Central)
143. ROS1 rearrangements define a unique molecular class of lung cancers. Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R, Mark EJ, Batten JM, Chen H, Wilner KD, Kwak EL, Clark JW, Carbone DP, Ji H, Engelman JA, Mino-Kenudson M, Pao W, Iafrate AJ (2012) J Clin Oncol 30(8): 863-70
     › Primary publication · 22215748 (PubMed) · PMC3295572 (PubMed Central)
144. Cell-associated hemolysis induced by Helicobacter pylori is mediated by phospholipases with mitogen-activated protein kinase-activating properties. Sitaraman R, Israel DA, Romero-Gallo J, Peek RM (2012) J Clin Microbiol 50(3): 1014-8
     › Primary publication · 22205825 (PubMed) · PMC3295145 (PubMed Central)
145. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ, European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva (2012) Endoscopy 44(1): 74-94
     › Primary publication · 22198778 (PubMed) · PMC3367502 (PubMed Central)
146. Extracting and integrating data from entire electronic health records for detecting colorectal cancer cases. Xu H, Fu Z, Shah A, Chen Y, Peterson NB, Chen Q, Mani S, Levy MA, Dai Q, Denny JC (2011) AMIA Annu Symp Proc : 1564-72
     › Primary publication · 22195222 (PubMed) · PMC3243156 (PubMed Central)
147. Early prediction of the response of breast tumors to neoadjuvant chemotherapy using quantitative MRI and machine learning. Mani S, Chen Y, Arlinghaus LR, Li X, Chakravarthy AB, Bhave SR, Welch EB, Levy MA, Yankeelov TE (2011) AMIA Annu Symp Proc : 868-77
     › Primary publication · 22195145 (PubMed) · PMC3243164 (PubMed Central)
148. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ, MAPS Participants, European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva (2012) Virchows Arch 460(1): 19-46
     › Primary publication · 22190006 (PubMed)
149. The gastric precancerous cascade. Correa P, Piazuelo MB (2012) J Dig Dis 13(1): 2-9
     › Primary publication · 22188910 (PubMed) · PMC3404600 (PubMed Central)
150. Pathogenesis of preeclampsia: the genetic component. Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE (2012) J Pregnancy : 632732
     › Primary publication · 22175024 (PubMed) · PMC3235819 (PubMed Central)
151. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Yan F, Wang L, Shi Y, Cao H, Liu L, Washington MK, Chaturvedi R, Israel DA, Cao H, Wang B, Peek RM, Wilson KT, Polk DB (2012) Am J Physiol Gastrointest Liver Physiol 302(5): G504-14
     › Primary publication · 22173918 (PubMed) · PMC3311435 (PubMed Central)
152. EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. Chmielecki J, Pietanza MC, Aftab D, Shen R, Zhao Z, Chen X, Hutchinson K, Viale A, Kris MG, Stout T, Miller V, Rizvi N, Pao W (2012) J Thorac Oncol 7(2): 434-42
     › Primary publication · 22173702 (PubMed) · PMC3261336 (PubMed Central)
153. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, Wilson KT, Zaika A, El-Rifai W (2012) Gut 61(9): 1250-60
     › Primary publication · 22157330 (PubMed) · PMC3419307 (PubMed Central)
154. Treatment of HER2-positive breast cancer: current status and future perspectives. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L (2011) Nat Rev Clin Oncol 9(1): 16-32
     › Primary publication · 22124364 (PubMed)
155. Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains. Li C, Sun Y, Fang R, Han X, Luo X, Wang R, Pan Y, Hu H, Zhang Y, Pao W, Shen L, Ji H, Chen H (2012) J Thorac Oncol 7(1): 85-9
     › Primary publication · 22071781 (PubMed)
156. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Suh YS, Lee HJ, Jung EJ, Kim MA, Nam KT, Goldenring JR, Yang HK, Kim WH (2012) Ann Surg Oncol 19(4): 1240-9
     › Primary publication · 22048633 (PubMed) · PMC3884694 (PubMed Central)
157. Integrated information systems for electronic chemotherapy medication administration. Levy MA, Giuse DA, Eck C, Holder G, Lippard G, Cartwright J, Rudge NK (2011) J Oncol Pract 7(4): 226-30
     › Primary publication · 22043185 (PubMed) · PMC3140443 (PubMed Central)
158. Coordinated regulation of caveolin-1 and Rab11a in apical recycling compartments of polarized epithelial cells. Lapierre LA, Ducharme NA, Drake KR, Goldenring JR, Kenworthy AK (2012) Exp Cell Res 318(2): 103-13
     › Primary publication · 22036648 (PubMed) · PMC3230713 (PubMed Central)
159. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS (2012) Cancer Epidemiol Biomarkers Prev 21(1): 20-38
     › Primary publication · 22028402 (PubMed) · PMC3315355 (PubMed Central)
160. Gained in translation: the importance of biologically relevant models of Helicobacter pylori-induced gastric cancer. Peek RM, Kuipers EJ (2012) Gut 61(1): 2-3
     › Primary publication · 21997557 (PubMed) · PMC3368554 (PubMed Central)
161. Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Chmielecki J, Peifer M, Viale A, Hutchinson K, Giltnane J, Socci ND, Hollis CJ, Dean RS, Yenamandra A, Jagasia M, Kim AS, Davé UP, Thomas RK, Pao W (2012) Genes Chromosomes Cancer 51(1): 54-65
     › Primary publication · 21938754 (PubMed)
162. EGFR mutant lung cancer. Gong Y, Pao W (2012) Curr Top Microbiol Immunol : 59-81
     › Primary publication · 21866438 (PubMed)
163. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. Girard N, Sima CS, Jackman DM, Sequist LV, Chen H, Yang JC, Ji H, Waltman B, Rosell R, Taron M, Zakowski MF, Ladanyi M, Riely G, Pao W (2012) Eur Respir J 39(2): 366-72
     › Primary publication · 21778168 (PubMed)
164. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ (2011) Neoplasia 13(2): 145-53
     › Primary publication · 21403840 (PubMed) · PMC3033593 (PubMed Central)
165. AKAP350 Is involved in the development of apical "canalicular" structures in hepatic cells HepG2. Mattaloni SM, Kolobova E, Favre C, Marinelli RA, Goldenring JR, Larocca MC (2012) J Cell Physiol 227(1): 160-71
     › Primary publication · 21374596 (PubMed) · PMC3899033 (PubMed Central)
166. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Chakrabarty A, Sánchez V, Kuba MG, Rinehart C, Arteaga CL (2012) Proc Natl Acad Sci U S A 109(8): 2718-23
     › Primary publication · 21368164 (PubMed) · PMC3286932 (PubMed Central)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword